🔸 The acquisition will expand Dotmatics’ presence in the bioprocessing market, particularly in the manufacturing of cell and gene therapies.
🔹 M-Star’s software offers accelerated analysis capabilities, superior user experiences, and rapid time-to-value in fluid dynamics simulations.
🔸 The company’s focus on graphics processing unit (GPU) acceleration allows for faster simulation times.
🔹 M-Star will remain a standalone business within Dotmatics, benefiting from new resources and strategic opportunities.
Introduction:
Scientific software specialist Dotmatics has acquired M-Star, a computational fluid dynamics (CFD) software company, to expand its presence in the bioprocessing market. The acquisition will provide Dotmatics with additional opportunities for innovation in the manufacturing of cell and gene therapies in life sciences R&D.
- M-Star’s differentiated CFD analysis product offers accelerated analysis capabilities, superior user experiences, and rapid time-to-value compared to other market solutions.
- M-Star’s focus on graphics processing unit (GPU) acceleration allows for faster simulation times, resulting in completed simulations in a fraction of the time compared to traditional modeling approaches.
- M-Star’s integrated post-processing tools enable real-time data analysis and photorealistic rendering, facilitating a deeper understanding of simulation results.
- The acquisition of M-Star provides Dotmatics with new opportunities to grow and scale, as well as access to financial and business development resources.
- M-Star will remain a standalone business within Dotmatics, with the founder, John Thomas, PhD, continuing to lead the company.
Conclusion:
Dotmatics’ acquisition of M-Star expands its presence in the bioprocessing market, particularly in the manufacturing of cell and gene therapies. The addition of M-Star’s differentiated CFD analysis product with accelerated analysis capabilities and GPU acceleration will allow Dotmatics to provide innovative solutions to its customers in the life sciences R&D field. This acquisition also provides Dotmatics with the opportunity to grow, scale, and access new financial and business development resources. Overall, this acquisition strengthens Dotmatics’ position as a leading scientific software specialist in the bioprocessing industry.
